包头医学院学报
包頭醫學院學報
포두의학원학보
JOURNAL OF BAOTOU MEDICAL COLLEGE
2015年
6期
112-113
,共2页
灯盏花素注射液%柴胡疏肝散%早期肝硬化
燈盞花素註射液%柴鬍疏肝散%早期肝硬化
등잔화소주사액%시호소간산%조기간경화
Breviscapine%Chaihu Shugan powder%Cirrhosis in early stage
目的：探究灯盏花素注射液联合柴胡疏肝散用于早期肝硬化患者的临床疗效。方法：选择60例早期肝硬化患者随机分为观察组和对照组，各30例。对照组患者给予灯盏花素注射液治疗，观察组患者在对照组的基础上服用柴胡疏肝散治疗。比较两组患者治疗有效率及肝功能指标的变化。结果：观察组患者的总有效率为86．66％，明显高于对照组66．67％（ P ＜0．05）；治疗前，两组患者的谷丙转氨酶（glutamic－pyruvic transaminase，ALT）、谷草转氨酶（glutamic oxalacetic transaminase，AST）以及胆红素（bilirubin，TBIL）的水平差异无统计学意义（ P ＞0．05），治疗后，两组患者的ALT、AST以及TBIL的水平较治疗前均降低，差异具有统计学意义（ P ＜0．05）。结论：使用灯盏花素注射液联合柴胡疏肝散能够使患者的ALT、AST以及TBIL水平显著降低，明显优于单独使用灯盏花素注射液患者的临床治疗效果，使患者病痛减轻，提高治疗效果、促进预后。
目的：探究燈盞花素註射液聯閤柴鬍疏肝散用于早期肝硬化患者的臨床療效。方法：選擇60例早期肝硬化患者隨機分為觀察組和對照組，各30例。對照組患者給予燈盞花素註射液治療，觀察組患者在對照組的基礎上服用柴鬍疏肝散治療。比較兩組患者治療有效率及肝功能指標的變化。結果：觀察組患者的總有效率為86．66％，明顯高于對照組66．67％（ P ＜0．05）；治療前，兩組患者的穀丙轉氨酶（glutamic－pyruvic transaminase，ALT）、穀草轉氨酶（glutamic oxalacetic transaminase，AST）以及膽紅素（bilirubin，TBIL）的水平差異無統計學意義（ P ＞0．05），治療後，兩組患者的ALT、AST以及TBIL的水平較治療前均降低，差異具有統計學意義（ P ＜0．05）。結論：使用燈盞花素註射液聯閤柴鬍疏肝散能夠使患者的ALT、AST以及TBIL水平顯著降低，明顯優于單獨使用燈盞花素註射液患者的臨床治療效果，使患者病痛減輕，提高治療效果、促進預後。
목적：탐구등잔화소주사액연합시호소간산용우조기간경화환자적림상료효。방법：선택60례조기간경화환자수궤분위관찰조화대조조，각30례。대조조환자급여등잔화소주사액치료，관찰조환자재대조조적기출상복용시호소간산치료。비교량조환자치료유효솔급간공능지표적변화。결과：관찰조환자적총유효솔위86．66％，명현고우대조조66．67％（ P ＜0．05）；치료전，량조환자적곡병전안매（glutamic－pyruvic transaminase，ALT）、곡초전안매（glutamic oxalacetic transaminase，AST）이급담홍소（bilirubin，TBIL）적수평차이무통계학의의（ P ＞0．05），치료후，량조환자적ALT、AST이급TBIL적수평교치료전균강저，차이구유통계학의의（ P ＜0．05）。결론：사용등잔화소주사액연합시호소간산능구사환자적ALT、AST이급TBIL수평현저강저，명현우우단독사용등잔화소주사액환자적림상치료효과，사환자병통감경，제고치료효과、촉진예후。
Objective:To investigate the clinical efficacy of the combination of breviscapine and chaihu shugan powder on patients with cirrho-sis in early stage.Methods:60 cases of patients were randomly divided into the control group (30 cases) given breviscapine and the observation group (30 cases) given breviscapine combined with Chaihu Shugan powder.The effective rate of treatment and the change of liver function index were compared between the two groups.Results:The total effective rate in the observation group was significantly higher than that in the control group(86.66 % vs.66.67 %, P <0.05).There was no significant difference in ALT, AST and TBIL between the two groups before treatment, but the level of ALT, AST and TBIL were significantly reduced in the two groups after treatment ( P <0.05).Conclusion:Breviscapine combined with Chaihu Shugan powder can significantly reduce patients'level of ALT, AST and TBIL, which is obviously superior to breviscapine when it is solely used in therapy in the clinical therapeutic effect and which can alleviate patients'pain, enhance the curative effect and improve its prognosis.
